All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves high-dose aflibercept ➤ Positive results in Phase 1 trial for cultivated autologous limbal epithelial cells ➤ Study: data from eye scans detect Parkinson’s disease years before clinical presentation ➤ Phase 2/3 study to evaluate persistent corneal epithelial defect treatment ➤ Phase 3 study offers results with aflibercept biosimilar ➤ ASCRS news and events
➤ First implantations for clinical trials for investigational IOLs ➤ Phase 2 clinical trial for wet AMD treatment completes enrollment ➤ Two-year results from trial showcase vision gains in wet AMD at extended aflibercept dosing intervals ➤ Acquisition update ➤ ASCRS news and events
➤ Positive Phase 3 results from trial investigating ocular pain, inflammation treatment ➤ Study evaluates use of sustained-release drug during Medicare pass-through program ➤ FDA approves treatment for geographic atrophy ➤ Dementia ‘much higher’ in patients with visual problems ➤ ASCRS news and events
The University of Southern California ophthalmology residents reviewed this article from a recent issue of the Journal of Cataract & Refractive Surgery.
➤ FDA approves first treatment targeting Demodex ➤ Phase 1 study compares mechanical dry eye treatment to drop therapy ➤ Topical gene therapy for rare ocular surface condition ➤ Glaucoma drug licensed for commercialization in U.S. ➤ ASCRS news and events
➤ Study: low-dose atropine doesn’t slow myopia progression ➤ Adverse events reported after use of FDA-approved geographic atrophy drug ➤ Phase 1 data for synthetic cannabinoid being investigated for glaucoma ➤ Enrollment complete in study evaluating topical diabetic retinopathy therapy ➤ Enrollment update for Phase 2b trial that could reduce AMD treatment burden ➤ ASCRS news and events
This article recaps the 2023 Richard L. Lindstrom, MD, Lecture, titled “Glaucoma Surgery: Taking it to the Next Level,” given by Marlene Moster, MD, as well as the other presentations in the session, given by Cathleen McCabe, MD, Francis Mah, MD, and Daniel Chang, MD.
The cataract patient who has had prior refractive surgery requires extra considerations in terms of consultations/patient expectations, IOL selection, formulas, use of intraoperative technologies, and postoperative potential. Two experts provided their thoughts on the modern management of these cataract patients.
Monday on the Main Stage at the ASCRS Annual Meeting featured the Charles D. Kelman, MD, Innovator’s Lecture, by William Link, PhD, and several other presentations on innovations from Sergio Canabrava, MD, Mark Lobanoff, MD, Richard Lewis, MD, Forrest Ellis, MD, and Elizabeth Yeu, MD.
➤ Phase 1/2 trial to evaluate intravitreal implant to delay cataract progression ➤ Update from Phase 1/2 proof-of-concept trial for chronic TED treatment ➤ First patient dosed for investigational, oral geographic atrophy treatment ➤ Pediatric study for pain, inflammation treatment following ocular surgery ➤ Complimentary access to video journal ➤ ASCRS news and events